Angelo Avogaro

发表

Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension.

A. Avogaro, A. Doria, G. Crepaldi, 1991, The American journal of physiology.

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly

A. Avogaro, F. Giorgino, C. Scaroni, 2015, Journal of Endocrinological Investigation.

Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition.

A. Avogaro, A. Tiengo, S. Del Prato, 2000, The Journal of clinical endocrinology and metabolism.

Potential manipulation of endothelial progenitor cells in diabetes and its complications

A. Avogaro, G. Fadini, Angelo Avogaro, 2010, Diabetes, obesity & metabolism.

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes

D. Bruttomesso, M. Marescotti, A. Avogaro, 2019, Journal of Endocrinological Investigation.

Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

D. Bruttomesso, M. Marescotti, A. Avogaro, 1999, Diabetes.

Glucose tolerance is negatively associated with circulating progenitor cell levels

A. Avogaro, A. Tiengo, A. Balbarini, 2007, Diabetologia.

One-year caloric restriction and 12-week exercise training intervention in obese adults with type 2 diabetes: emphasis on metabolic control and resting metabolic rate

E. Ravussin, G. Sergi, F. Zurlo, 2019, Journal of Endocrinological Investigation.

Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes

L. Magni, C. Cobelli, G. Lanzola, 2015, Diabetes, obesity & metabolism.

Gemfibrozil improves insulin sensitivity and flow‐mediated vasodilatation in type 2 diabetic patients

G. Pacini, A. Avogaro, A. Tiengo, 2001, European journal of clinical investigation.

Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high‐risk nondiabetic patients

A. Avogaro, A. Pessina, F. Dorigatti, 2006, Journal of internal medicine.

Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields.

A. Avogaro, M. Varano, S. Vujosevic, 2009, American journal of ophthalmology.

Development of metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects

M. Marescotti, A. Avogaro, G. Fadini, 2013, Journal of Endocrinological Investigation.

A perspective on sirtuins in the metabolic syndrome.

A. Avogaro, G. Fadini, M. Albiero, 2015, Metabolic syndrome and related disorders.

Treating diabetes today with gliclazide MR: a matter of numbers

A. Avogaro, Angelo Avogaro, 2012, Diabetes, obesity & metabolism.

Myocardial Metabolism in Type 1 Diabetic Patients Without Coronary Artery Disease

A. Avogaro, A. Doria, G. Crepaldi, 1991, Diabetic medicine : a journal of the British Diabetic Association.

Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects

A. Maran, I. Macdonald, A. Avogaro, 2000, Diabetologia.

Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes

A. Avogaro, D. Pizzol, S. Vigili de Kreutzenberg, 2015, Andrology.

Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition.

C. Crepaldi, S. Marchetto, S. D. Prato, 2000, The Journal of clinical endocrinology and metabolism.

The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans

A. Maran, A. Avogaro, A. Tiengo, 1992, Diabetologia.

Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.

A. Avogaro, G. Ceolotto, A. Gallo, 1999, Diabetes.

A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus

S. D. Prato, Paola Fioretto, Angelo Avogaro, 2017, Expert review of clinical pharmacology.

Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies

A. Avogaro, G. Fadini, I. Baldi, 2020, Journal of Endocrinological Investigation.

Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes

D. Bruttomesso, A. Avogaro, G. Fadini, 2020, Journal of Endocrinological Investigation.

Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.

M. Marescotti, A. Avogaro, A. Tiengo, 1993, Metabolism: clinical and experimental.

The metabolic syndrome

A. Tiengo, G. Crepaldi, Angelo Avogaro, 2015 .

Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease.

G. Fadini, G. Semenzato, E. Boscaro, 2009, Clinical and experimental rheumatology.